TESTING

How Alzheimer's is diagnosed, and why the years before diagnosis matter

Alzheimer's is diagnosed when cognitive changes have become noticeable enough to evaluate. But the biology can begin 15 to 20 years earlier. That earlier window is where BetterBrain focuses: understanding your risk, establishing a baseline, and improving the parts of brain health you can influence before a diagnosis.

IN THIS ARTICLE
How Alzheimer's is diagnosed
The timeline most people miss
What each test can tell you
What pTau-217 changes
What you can do before a diagnosis
Common questions
Key takeaway:

BetterBrain does not diagnose Alzheimer's disease. If you are experiencing meaningful cognitive changes, the right next step is a clinical evaluation. BetterBrain is built for the years before that point, when you can understand your cognitive baseline, measure modifiable risk factors, and build a plan to support your brain health over time.

Blueprint combines a cognitive assessment, 50+ brain-relevant biomarkers, family and health history, and a Brain Health Coach. $89 with insurance, $399 cash pay.
See your options

How Alzheimer's is actually diagnosed

There is no single test that diagnoses Alzheimer's on its own. A clinician usually starts with what has changed: memory, navigation, repeated questions, medications, finances, work, or other daily tasks.

A short cognitive test may follow. Blood work can help identify other conditions that can cause or worsen cognitive symptoms, including thyroid dysfunction or vitamin B12 deficiency. Brain imaging, often an MRI, can look for strokes, tumors, hydrocephalus, or patterns of brain atrophy.

Then there is the biomarker layer. PET imaging, cerebrospinal fluid tests, and newer blood biomarkers such as pTau-217 can provide evidence that Alzheimer's-related amyloid and tau pathology is present. These pieces are interpreted together. A biomarker is not a diagnosis by itself, and a cognitive score is not a diagnosis by itself.

WHERE BETTERBRAIN FITS, AND WHERE IT DOESN'T

BetterBrain does not diagnose Alzheimer's disease. Diagnosis is the job of a clinician. BetterBrain focuses on a different part of the timeline: the years when someone may still feel well but wants to understand their brain health and take action earlier.

The part of the Alzheimer's timeline most people never hear about

Alzheimer's-related changes can begin 15 to 20 years before memory problems become obvious. That can sound frightening, but it also means there is a long period when someone can still feel completely well and have time to work on factors associated with long-term brain health.

You do not have to wait for memory loss to learn your blood pressure, ApoB, blood sugar, insulin, B12, homocysteine, inflammation, or cognitive baseline. You do not have to wait for a diagnosis to improve your fitness, sleep, metabolic health, hearing, nutrition, or cardiovascular health.

And there is no single age at which brain health suddenly starts to matter. At every stage of adulthood, there are things you can do to support how well your brain functions now and how well you age.

See your options
Blueprint shows you 50+ biomarkers, a cognitive baseline, lifestyle and family-history factors, then turns that information into a prioritized plan.

What each Alzheimer's test can and cannot tell you

Cognitive testing. A cognitive screen tells you how you are performing today. It can identify a pattern that deserves closer evaluation and give you a baseline to compare over time. It cannot tell you by itself why your score is what it is.

Basic blood work. Blood tests can identify treatable contributors to cognitive symptoms. They do not diagnose Alzheimer's.

MRI. MRI can help rule out structural causes and may show patterns consistent with neurodegeneration. It does not confirm Alzheimer's on its own.

Alzheimer's biomarkers. Biomarkers look at disease biology more directly. They may measure amyloid or tau through PET imaging, cerebrospinal fluid, or blood. They can show that Alzheimer's-related pathology may be present, but cannot tell you with certainty whether symptoms will develop, when they would begin, or how quickly anything would progress.

What pTau-217 changes

pTau-217 is important because it makes one part of Alzheimer's biology much easier to measure.

When Alzheimer's-related changes begin developing in the brain, blood pTau-217 can rise before symptoms appear. That gives researchers and clinicians a new way to see biology that previously often required a PET scan or lumbar puncture.

But BetterBrain's view is that access to the test is only useful if the result comes with context.

A pTau-217 result does not tell you why one person with Alzheimer's-related pathology remains cognitively healthy for years while another develops symptoms. It also does not tell you about the many modifiable factors that affect overall dementia risk.

BetterBrain does not treat pTau-217 as a standalone answer. It is an optional add-on to a broader brain-health assessment. See everything we test →

What can you do before a diagnosis?

The 2024 Lancet Commission identified 14 modifiable risk factors associated with dementia, including hearing loss, high LDL cholesterol, hypertension, diabetes, physical inactivity, smoking, depression, excess alcohol, obesity, social isolation, and vision loss.

Those are population-level risk factors, not a checklist everyone needs to attack at once. Someone with high ApoB and insulin resistance needs a different plan from someone with excellent metabolic health but untreated hearing loss, poor sleep, and low physical activity.

Your job is to figure out which ones actually apply to you.

That is what personalization means at BetterBrain. Not doing everything. Knowing where to start.

BETTERBRAIN PERSPECTIVE

Alzheimer's-related pathology can become detectable years before symptoms, but detecting pathology is not the same as diagnosing dementia. Early information is most useful when it gives you something meaningful to act on across cognition, vascular health, metabolic health, family history, and the factors you can still change.

Book a BetterBrain coaching session
$0 with insurance for eligible clients.

Common questions

No. BetterBrain does not diagnose Alzheimer's disease. If you are having cognitive symptoms, you should seek a clinical evaluation. BetterBrain focuses on brain health and dementia-risk reduction before diagnosis by helping you understand cognition, biomarkers, lifestyle, family history, and modifiable risk factors.

A blood biomarker can provide evidence that Alzheimer's-related pathology is present, but it is interpreted as part of a broader clinical picture. It does not independently tell you whether or when you will develop symptoms.

Usually a clinical history and cognitive assessment, often followed by blood work and, when appropriate, imaging or biomarker testing.

Start with the factors you can act on now. Establish a cognitive baseline, know your cardiovascular and metabolic numbers, address hearing and sleep, stay physically active, and decide whether genetic or Alzheimer's biomarker testing would change your plan.

A diagnosis is one point in time. Brain health is something you work on for years before it.

BetterBrain is built for the earlier part of the story, when the goal is not to label disease, but to understand your risk, improve your brain health, and make the most of the time you have to act.

92% of eligible clients pay $0 per session
Book a BetterBrain coaching session